Showing posts with label vaccine. Show all posts
Showing posts with label vaccine. Show all posts

Thursday, March 31, 2011

Cat Allergy Vaccine Safe and Effective, Study Suggests

ScienceDaily (Mar. 31, 2011) — Good-bye itching, watering eyes and sneezing. McMaster University researchers have developed a vaccine which successfully treats people with an allergy to cats.

........

Source

Sunday, July 19, 2009

Swine Flu Vaccinations Could Prove More Deadly Than the Swine Flu

Bill Lindner
Austrian Investigative Journalist Jane Buergermeister (Bürgermeister) who recently filed criminal charges against the World Health Organization (WHO), the United Nations (UN) and several high-ranking Goverment and corporate officials concerning bioterrorism involving Swine Flu vaccines that could prove to be more deadly than the disease was fired from her job -- writing for Renewable Energy World -- earlier this week, apparently because she filed those charges, and that is unacceptable. Readers wishing to help her can read more about that on her blog.

Evidence that many organizations as well as Pharmaceutical companies such as Baxter and Novartis who merged with Chiron are part of a system controlled by a crime syndicate responsible for funding the development, manufacturing and release of artificial viruses with the intention of justifying mass vaccinations with a bioweapon substance to eliminate the people of the U.S. and to gain control of North America's assets and resources was produced by Burgermeister.

Burgermeister says the crime syndicate sets its goals using the Trilateral Commission and Bilderberg meetings, identifying the 'Illuminati,' a mafia-like group with family dynasties -- a global crime syndicate based in off-shore banking centers -- that employs international organizations such as the WHO and the UN.

The lawsuit filed by Burgermeister alleges that the Swine Flu pandemic was manufactured as part of a long term plan by the crime syndicate, who built large numbers of FEMA concentration camps with incinerators and prepared mass graves in states that include Indiana and New York to quarantine people and dispose of bodies of the people killed by the bioweapons attack.

Information on funding for the crime syndicate can be found in this article from InfoWars. Burgermeister also contends that there is evidence that Baxter AG, an Austrian subsidiary of Baxter International, deliberately sent 72 kilos of live bird flu virus, supplied by the WHO in the winter of 2009, to 16 laboratories in 4 countries. More on her charges can be found in this 'Swine Flu Outbreak or Bioterrorism and Intent to Commit Mass Murder?' article.

Number of Deaths does not Justify a Pandemic

A recent report by Dr. Russell Blaylock highlights dangers of the Swine Flu vaccine about to be thrust upon the world courtesy of the outbreak of the Swine Flu in Mexico this past April when President Obama -- who is also named in Burgermeister's lawsuit -- visited there.

The Swine Flu outbreak, according to Dr. Blaylock's figures, eventually affected 4,910 Mexican citizens and resulted in 85 deaths. Once the flu spread to the U.S. -- due to air travel and the failure of health officials to control travel from Mexico -- it caused primarily mild cases of flu-like illness. Now the virus has been spread worldwide.

Contrary to predictions of a massive amount of deaths and the WHO's manipulations making it possible for them to call it a pandemic, the virus has remained relatively mild, as happens each year with flu epidemics. There have been 311 deaths worldwide out of 70,893 cases diagnosed. The U.S. has had 27,717 cases that have resulted in 127 deaths. It's sad that people have died from this virus, but such low numbers do not come close to being pandemic and should not be the basis of implementing egregiously draconian government policies.

As noted by Dr. Blaylock, it's helpful to recall that the Centers for Disease Control, with the collusion of the media, constantly tells us that 36,000 people die from the flu each year, a figure that has been shown to be a lie. With the Swine flu, we're talking about a little over 300 deaths for the entire world. It's also interesting to note that the WHO said that the H1N1 flu pandemic is moving around the globe at an 'unprecedented' speed but stopped giving figures on numbers affected.

Scandal-ridden Companies Hurriedly Creating Pandemic Vaccine

Extensive analysis of the swine flu virus revealed that it contained the original 1918 H1N1 flu virus, the avian (bird) flu virus and 2 new H3N2 virus genes from Eurasia, meaning that it had to be genetically created in a laboratory.

Both Baxter Pharmaceuticals and Novartis Pharmaceuticals -- recently acquired from scandal-ridden Chiron vaccine company -- have agreements with the WHO to come up with a pandemic vaccine.

Baxter Pharmaceuticals has been involved in a few deadly scandals in the past couple decades. In 1996 hemophilia components were contaminated with HIV virus and injected into tens of thousands of people, including thousands of children. Even when the contamination became known, Baxter continued to release the HIV contaminated clotting substance. Baxter has had a couple of major scandals because of Heparin.

Earlier this year Baxter Pharmaceuticals was caught in what appeared to be an attempted worldwide release of a weaponized version of the H591 Avian Flu Virus that had been mixed with seasonal H3N2 flu viruses. It was shipped to at least 18 countries, despite the fact that it's virtually impossible for that type of contamination to mistakenly occur. It appears to have been intentional. Despite the scandals and the deadly events, WHO has an agreement with Baxter to produce pandemic vaccine to be used worldwide.

Immune Adjuvants Found to be Deadly to Animals

Celvapan, the vaccine created by Baxter, uses a new vero cell technology that utilizes cultured cells from the African green monkey -- the same animal tissue that transmits the HIV virus, among a number of other vaccine-contaminating viruses -- has had fast track approval.

According to Dr. Blaylock, the terrifying thing about these pandemic vaccines is that they contain ingredients called immune adjuvants -- pharmacological or immunological agents used to modify the effect of other agents -- that a number of studies have shown cause devastating autoimmune disorders including rheumatoid arthritis, multiple sclerosis and lupus.

Animal studies using this adjuvant were found to be deadly -- when 14 guinea pigs were injected with the special adjuvant, only 1 animal survived -- not once, twice. Both studies had the same deadly outcome. Numerous studies have shown that squalene can trigger the autoimmune disorders mentioned above.

Swine Flu Vaccinations Could Prove More Deadly Than the Swine Flu

The deadly ingredient in the immune adjuvant is called squalene. The Chiron company, maker of the deadly anthrax and flu vaccines makes an adjuvant called MR-59 that contains squalene and gp120. Several vaccines have used Chiron's MF-59 adjuvant, including tetanus and diptheria, that has been frequently associated with adverse reactions.

Squalene has been attributed strongly to Gulf War Syndrome too. In the summer of 1991 the Secretary of Veterans Affairs admitted that soldiers who were vaccinated with anthrax vaccine from 1990 to 1991 had a 200 percent increased risk in developing a deadly disease called Amyotrophic Lateral Sclerosis (ALS). Courtesy of the U.S. government, soldiers were also recipients of a number of debilitating and life-shortening diseases.

Dr. Blaylock reviewed several studies -- a number of which appeared in 'prestigious' medical journals claiming that it was a very safe adjuvant for humans -- on MR-59 and found, to no great surprise, that a great number of the studies were done by Novartis Pharmaceutical Company and Chiron Pharmaceuticals. A great number of studies done by independent laboratories and research institutions all found strong links between MF-59 and autoimmune diseases. Results of the Pharmaceutical studies are misleading, primarily because their results are based on one to two week time frames, when in reality, it can take years for the deadly reactions of the vaccines to manifest. Taking that vaccine could result in a lifetime of crippling illness and early death.

Some of the deadly dangers of Squalene -- the main ingredient in MF-59 -- can be found in Dr. Blaylock's article. The vaccines being rushed to market by these large pharmaceutical companies who stand to make billions of dollars in profits from the WHO as well as the U.S. and numerous other governments could kill a hell of a lot more people than the Swine Flu. One thing to keep in mind, as noted by Dr. Blaylock, is the fact that there is little you can do to protect yourself -- at least with conventional medicine -- once you receive an injection of the vaccine. Dr. Blaylock recommends a good diet, higher doses of vitamin D3 and selective immune enhancement using supplements to protect yourself from the Swine Flu virus.

A CBS "60 Minutes" expose that was only shown once looks at the great, falsely manufactured, Swine Flu scare of 1976 when 46 million Americans took the vaccine and 4000 ended up seeking damages that amounted to $3.5 billion due to neurological problems and death should serve as a precaution, not to mention evidence of how the government fraudulently and falsely creates disasters to intentionally scare the masses while killing an untold number of people. The last eight and a half years of U.S. government malfeasance also serves as a perfect example of why NOT to trust the government. Goverment propaganda causes many deaths.

The quick elevation of this 'swine flu outbreak' to pandemic status with such low death numbers makes absolutely no sense whatsoever. More background on the alleged pandemic and why to be suspicous of it can be found in this 'swine flu outbreak or bioterrorism and intent to commit mass murder?' article. It appears that this pandemic is an example of history repeating itself, but this time the results will probably end up being a lot worse because the swine flu vaccinations could prove more deadly than the swine flu.

Saturday, January 10, 2009

Novel Vaccine Taking Aim At Cancer Cell "Sweet Spot"

Article Date: 09 Jan 2009

Molecules of sugar sitting on the surface of cancer cells are keys to the development of a new vaccine aimed at both treating and stopping the spread of certain types of cancers called carcinomas, which include prostate, breast, ovarian and lung, among others. Armed with a new two-year grant for $600,000 from the Gateway for Cancer Research, an Illinois-based philanthropic foundation, immunologist Alessandra Franco, M.D., Ph.D., and her co-workers at the Moores Cancer Center at the University of California, San Diego are hoping to develop a low-cost immunotherapy for prostate carcinoma that may also have use against a variety of other carcinomas as well.

Franco, adjunct assistant professor of pediatrics at the UC San Diego School of Medicine, and her co-workers have spent the last decade proving that the immune system's destructive, or "killer," T-cells can recognize sugars on tumor cell surfaces. Her laboratory pioneered and developed the notion that conventional T-cells recognize not only peptides, or pieces of proteins, but also sugars, specifically small carbohydrates called tumor-associated carbohydrate antigens (TACA) expressed on carcinoma cell surfaces. Ideally, this recognition enables the T-cell to attach to and kill the cancer cell.

The researchers have designed "glycopeptides," compounds in which sugars are linked to peptides that are recognized by T-cells. When given as part of a vaccine therapy, these glycopeptides rouse immune system T-cells into recognizing TACA on tumor cell surfaces, attacking and killing the cancer cells. Her research team has already shown that both normal mice and mice with tumors that were vaccinated could successfully generate carbohydrate-specific T-cells that could kill tumors expressing the same carbohydrate molecule.

Cancer vaccines have had a mixed record of success at best. Most immunotherapies have focused on revving up immune system antibodies to recognize proteins on tumor cells.

"A limitation with current immunotherapies is that every tumor expresses different protein antigens, which all need to be characterized," she explained. "It is difficult for the immune system to discriminate, to tell that cancer cells are 'non-self' and should be destroyed. What's nice about T-cells recognizing sugars and why it's so important in cancer is because the same molecules are uniquely expressed in a large variety of cancers." A cell that becomes cancerous begins making a variety of sugar molecules that are not expressed in normal adult cells, making this strategy potentially useful for wide-ranging treatments of different tumors. Her team is targeting a sugar that is expressed on all carcinomas, a type of cancer that begins in epithelial cells.

Studies in the first year of the grant are focusing on gathering further laboratory and preclinical data to show the vaccine's effectiveness. Franco is hoping to begin a clinical trial in the second year of the grant to test the vaccine on prostate cancer patients who have already had treatment but who are at extremely high risk for relapse. She sees the vaccine as being used to help prevent the spread of cancer (metastatic disease), and perhaps even in preventing cancer in healthy people.

"The beauty of this approach is that the same vaccine may prevent metastasis," she said, noting that tumor cells can use sugar or carbohydrate antigens to spread. "If ultimately proven successful, this could be used in a first attempt to try to address vaccination on a large scale to prevent cancer."

The same type of vaccine can potentially be used for breast, lung, liver, ovary and other carcinomas, Franco said. "If we can show that this system works in humans, we think that it can address a variety of tumors with the same sugar compounds." The vaccine's relatively simple formulation, stability and low production cost could make it ideal for use in developing countries, she added.

The Moores UCSD Cancer Center is one of the nation's 41 National Cancer Institute-designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer. For more information, visit http://www.cancer.ucsd.edu.

University of California San Diego
University Communications, 0938... Gilman Dr.
LaJolla
CA 92093
United States
http:// www.ucsd.edu

Source

Tuesday, September 30, 2008

A DNA-based vaccine shows promise against avian flu

Posted: September 30, 2008

Though it has fallen from the headlines, a global pandemic caused by bird flu still has the United States’ Centers for Disease Control and Prevention on high alert. Yet, to date, the only vaccines that have proven even semi-effective are produced in chicken eggs, take five to six months to prepare and act against a single variant of the H5N1 virus, which mutates incredibly quickly. Now, new research by scientists in New York and Taiwan has led to a vaccine with the potential to stop most strains of H5N1 flu viruses in their tracks.

David D. Ho, Rockefeller’s Irene Diamond Professor and scientific director of the Aaron Diamond AIDS Research Center, together with his colleagues at Taiwan’s Academia Sinica, has built a vaccine that stimulates immunity to a broad range of H5N1 viruses in mice by using DNA rather than dead virus particles grown in eggs. Such a vaccine, which consists of plasmid DNA that’s been genetically modified to elicit specific immune responses, is much easier to rapidly modify and produce — critical advantages when racing to prevent an epidemic.

Ho and his collaborators first had to address virus specificity: Because H5N1 viruses are incredibly diverse, and mutate fast, the researchers created a consensus sequence that incorporated all of the conserved parts of the gene encoding the virus’s outer protein. Then they had to figure out how to deliver it.

This is where DNA vaccines often fail. They aren’t very good at making sure the DNA gets where it needs to go. To solve this problem, Ho and his colleagues turned to electroporation, a technique that is just beginning to gain traction in the vaccine world and that, according to preliminary studies, helps increase uptake of the vaccine. By combining their consensus-sequence vaccine with a small electric stimulus, the researchers found that their mouse subjects responded with an incredibly broad immune reaction.

“The immune responses directed to our DNA vaccine seem to be very broad,” Ho says. “It could be that the vaccine in its current form could protect against most of the H5N1 viruses out there.” And even if it can’t, he notes, if a different strain of H5N1 begins to circulate, it should only take a few days to obtain its genetic sequence and adapt the existing vaccine to fight it.

A version of the consensus vaccine is already being produced, Ho says, so that it can move into human clinical trials as quickly as possible. And a separate electroporation study is under way at The Rockefeller University Hospital, this one examining the effectiveness of electroporation combined with a DNA vaccine against HIV.

Proceedings of the National Academy of Sciences 105(36): 13538–13543 (September 9, 2008)

Contact: Zach Veilleux 212-327-8982
newswire@rockefeller.edu

Source
*
*